重組人干擾素α2b陰道泡騰片治療宮頸高危型hpv感染的療效分析范本-wenkub
2023-07-10 04:13:51 本頁面
【正文】 lets， 58 cases） and the control group （regular followup， 57 cases）， after the treatment， the HPV negative rate and adverse reaction of the two groups were pared. Results The total negative rate of HPV in the experimental group was %， significantly higher than that in the control group of %， the difference was statistically significant（P）， the patients had no obvious disfort， and the adverse reaction rate was %. Conclusion Rebinant human interferon α2b vaginal effervescent tablets in the treatment of cervical highrisk HPV infection has good curative effect and no obvious side effects. It is safe and worthy to be popularized. [Key words] Highrisk HPV infection； Cervical mucosa chronic inflammation； Cervical intraepithelial neoplasia 1； Rebinant human interferon α2b vaginal effervescent tablets HPV為乳多空病毒科乳頭瘤空泡病毒A屬球形DNA病毒，具有傳染性，多見于皮膚及女性生殖道，可引起多種疾病，人群感染率高[1]。方法 方便選取2016年6月―2017年4月該院收治的115例宮頸高危型HPV感染患者為研究對象，依據(jù)治療方法不同分為實驗組（重組人干擾素α2b 陰道泡騰片，58例）和對照組（定期隨訪觀察不做處理，57例）。療程結(jié)束后，統(tǒng)計2組HPV轉(zhuǎn)陰率，觀察實驗組用藥不良反應(yīng)。目前，臨床分離出的HPV
環(huán)評公示相關(guān)推薦
鄂ICP備17016276號-1